跳至主要内容
临床试验/NCT01823887
NCT01823887已完成1 期

Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study

Cyberonics, Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年7月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Cardiac Function

研究概览

简要总结

The ANTHEM-HF Study is designed to demonstrate the safety and efficacy of vagus nerve stimulation (VNS) with the Cyberonics VNS Therapy System for the treatment of subjects with symptomatic heart failure.

详细描述

Heart failure patients will be enrolled and randomized to cervical VNS implantation on either the left side or right side. After a 2-week post-implantation recovery period and a 10-week stimulation titration period, continuous periodic stimulation will be performed for 6 months, with data collection at 3 months and 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic heart failure, New York Heart Association (NYHA) class II/III with reduced EF and dilated hearts

排除标准

  • 未提供

结局指标

主要结局

Cardiac Function

时间窗: 6 months

Left ventricular end-systolic volume (LVESV) and ejection fraction (EF)

Adverse Events

时间窗: 6 months

Incidence of procedure and device-related complications

次要结局

  • Autonomic Function(6 months)
  • Quality of Life(6 months)
  • Blood Biomarkers(6 months)
  • Cardiac Function(6 months)
  • Functional Status(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验